Karen Lin

Ms. Karen Lin

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2025 in Toxicology Letters
Verified
Journal Article
Closed access
YSYehao Sun
Yehao Sun
KLKaren Lin
Karen Lin
FEFelix Effah
Felix Effah
FCFrancisco Cartujano-Barrera
Francisco Cartujano-Barrera
Dongmei LiDongmei Li
Dongmei Li
Irfan RahmanIrfan Rahman
Irfan Rahman

9 January 2026 in Toxicology Reports
Verified
Journal Article
Open access
KLKaren Lin
Karen Lin
YSYehao Sun
Yehao Sun
RRRhea Raghu
Rhea Raghu
PSParth Suharu
Parth Suharu
Felix EffahFelix Effah
Felix Effah
Irfan RahmanIrfan Rahman
Irfan Rahman
Hemp-derived cannabinoids (CBDs) such as Δ8- and Δ10-tetrahydrocannabinol (THC) in cannabis e-cigarettes have been growing in popularity among youth, causing great concern for their health effects. Previous novel lung injury outbreaks, such as E-cigarette or Vaping Use-Associated Lung Injury (EVALI), were associated with the rising use of e-cigarettes and vaping products. Toxicological studies have revealed that chronic exposure to cannabis vapor can cause adverse brain and pulmonary effects. Hemp products are classified as cannabis and set a limit of no more than 0.3 % Δ9-THC, while products containing more than 0.3 % are defined as ‘marijuana.’ This has led to the proliferation of hemp-derived intoxicating cannabinoids, such as Δ8- and Δ10-THC, in addition to cannabidiol (CBD), cannabinol (CBN), cannabigerol (CBG), and Δ9-THC appearing in combination products. CBD frequently serves as a significant component of hemp-derived formulations, making it a central consideration for toxicological and regulatory evaluation as well. This phenomenon poses significant health risks to youth because these newer THC isomers and products are currently unregulated and not well-researched, yet they are still widely available. Therefore, we have examined the pharmacology, toxicity, potential therapeutic uses and possible health risks of several THC and hemp-derived cannabinoids. This review draws insightful highlights to the public health consequences of secondary exposures to CBD and THC, and their molecular mechanisms of action. It underscores the urgency for a regulatory oversight over unregulated cannabinoid markets to prevent toxicity of vaping-related health crises and other rapidly emerging cannabis health disorders, like the cannabinoid hyperemesis syndrome (CHS).

12 September 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
KLKaren Lin
Karen Lin
YSYehao Sun
Yehao Sun
RRRhea Raghu
Rhea Raghu
PSParth Suharu
Parth Suharu
FEFelix Effah
Felix Effah
Irfan RahmanIrfan Rahman
Irfan Rahman
Hemp-derived cannabinoids (CBDs) such as Δ8- and Δ10-tetrahydrocannabinol (THC) in cannabis e-cigarettes have been growing in popularity among youth, causing a great concern for their health effects. Previous novel lung injury outbreaks, namely E-cigarette or Vaping Use-Associated Lung Injury (EVALI), were associated with the rising use of e-cigarettes and vaping products. Toxicological studies have revealed that chronic exposure to cannabis vapor can cause adverse brain and pulmonary effects. Federal regulatory policies like the United States 2018 Farm Bill classify hemp as cannabis and set a limit of no more than 0.3% Δ9-THC, while products containing more than 0.3% are defined as ‘marijuana.’ This regulatory loophole has led to the proliferation of hemp-derived intoxicating cannabinoids, such as Δ8- and Δ10-THC, in addition to cannabidiol (CBD), cannabinol (CBN), cannabigerol (CBG) and Δ9-THC appearing in combination products on the market. This phenomenon poses significant health risks to youth because these newer THC isomers and products are currently unregulated and not well-researched, yet they are still widely available. Therefore, we have examined the potential therapeutical uses, toxicity, pharmacology, and possible health risks of several THC and hemp-derived cannabinoids. This review also draws insightful highlights to the public health consequences of secondary exposures to CBD and THC, and their molecular mechanisms of actions. It underscores the urgency for a strict regulatory oversight over unregulated cannabinoid markets to prevent other vaping-related health crises and other rapidly emerging cannabis health disorders, like the cannabinoid hyperemesis syndrome (CHS).